Dawn A. Brooks
Dawn A. Brooks publishes mostly in Organic Chemistry, Physiology and Molecular Biology, on topics such as Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research and Peroxisome Proliferator-Activated Receptors.
- World rank
- #711,776 of 7,710,434 ranked researchers
- Rank in United States
- #240,271 of 1,627,098
- Works
- 42
- Citations
- 4.3k
- Citations per work
- 103.2
What does Dawn A. Brooks research?
Dawn A. Brooks's work is mostly in Medicine (39%), Chemistry (27%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1639.1%
- Medicine1639.1%
- Physical Sciences1126.8%
- Chemistry1126.8%
- Everything else818.7%
- Life Sciences615.4%
- 1Organic Chemistry27% of their works
- 2Physiology17% of their works
- 3Molecular Biology15% of their works
- 4Psychiatry and Mental health12% of their works
- 5Neurology6% of their works
- 6Pharmacology4% of their works
Research topics
- Alzheimer's disease research and treatments
- Dementia and Cognitive Impairment Research
- Peroxisome Proliferator-Activated Receptors
- Asymmetric Synthesis and Catalysis
- Intracerebral and Subarachnoid Hemorrhage Research
- Synthetic Organic Chemistry Methods
- Cholinesterase and Neurodegenerative Diseases
- Receptor Mechanisms and Signaling
Which keywords describe Dawn A. Brooks's research?
The keywords of their largest research topics: Neuroinflammation, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Enantioselective Reactions and Organocatalysis.
- Crystal Structure
- Olefin Metathesis
- Acetylcholinesterase
- Cerebral Amyloid Angiopathy
- Peroxisome Proliferator-Activated Receptors
- Organocatalysis
- Mild Cognitive Impairment
- Alzheimer's Disease
- Amyloid Hypothesis
- Neuroinflammation
- Tau Pathology
- Dementia
- Enantioselective Reactions
- PPARs
- Pharmacology
- Intracerebral Hemorrhage
- Cholinesterase Inhibitors
- Ruthenium Catalysts
- G-Protein-Coupled Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Neuroinflammation232 topics
- Amyloid Hypothesis181 topic
- Tau Pathology181 topic
- Alzheimer's Disease152 topics
- Dementia111 topic
- Mild Cognitive Impairment111 topic
- Enantioselective Reactions71 topic
- Organocatalysis71 topic
- PPARs71 topic
- Peroxisome Proliferator-Activated Receptors71 topic
- Pharmacology72 topics
- Cerebral Amyloid Angiopathy51 topic
- Intracerebral Hemorrhage51 topic
- Acetylcholinesterase41 topic
- Cholinesterase Inhibitors41 topic
- Olefin Metathesis41 topic
- Ruthenium Catalysts41 topic
- Crystal Structure31 topic
- G-Protein-Coupled Receptors31 topic
Where does Dawn A. Brooks work?
Dawn A. Brooks's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Dawn A. Brooks have?
OpenAlex counts 42 works and 4,335 citations for Dawn A. Brooks, an h-index of 19, ranking #711,776 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dawn A. Brooks. Posts are plain text and can be reported.